Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 443.50 INR
Change Today -1.80 / -0.40%
Volume 237.1K
BIOS On Other Exchanges
Natl India
As of 7:05 AM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

biocon ltd (BIOS) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/15/15 - 495.70
52 Week Low
08/24/15 - 395.30
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOCON LTD (BIOS)

Related News

No related news articles were found.

biocon ltd (BIOS) Related Businessweek News

No Related Businessweek News Found

biocon ltd (BIOS) Details

Biocon Limited, an integrated healthcare company, develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, and narrow spectrum antibiotics; and biosimilars comprising human insulin, insulin glargine, insulin lispro, insulin aspart, erythropoietin, filgrastim, streptokinase, and monoclonal antibodies. The company also provides branded formulations in the areas of cardiology, diabetology, oncology, nephrology, cardiology, immunotherapy, and comprehensive care; and out-licensing services. In addition, it offers contract manufacturing services, including mammalian cell culture fermentation, microbial cell culture fermentation, and synthetic chemistry to small-to-medium sized pharmaceutical and biotech companies; undertakes clinical research activities on discovering new biomarkers; and provides integrated contract research services to support discovery and development, for small and large molecules. The company’s principal brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab), and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It serves its customers in approximately 85 countries. The company was founded in 1978 and is headquartered in Bengaluru, India.

7,528 Employees
Last Reported Date: 06/23/15
Founded in 1978

biocon ltd (BIOS) Top Compensated Officers

Chief Executive Officer, Joint Managing Direc...
Total Annual Compensation: 25.5M
Founder, Chairperson, Managing Director, Memb...
Total Annual Compensation: 14.7M
Chief Financial Officer and President of Fina...
Total Annual Compensation: --
Vice Chairman, Member of Share Transfer Commi...
Total Annual Compensation: 14.8M
Senior Vice President
Total Annual Compensation: --
Compensation as of Fiscal Year 2015.

biocon ltd (BIOS) Key Developments

Biocon Inaugurates Devices Facility in Bangalore

Biocon Ltd. inaugurated a facility for manufacturing new generation, patient-friendly devices for its insulins portfolio. The 100,000 square feet, new devices facility set up in Bangalore is an outcome of Biocon's commitment to 'Make in India for the World' which is well aligned with the Government's 'Make in India' vision to transform the country into a global manufacturing hub. The facility will enable Biocon to leverage the country's manufacturing expertise to develop world-class delivery devices for people with diabetes in India and other parts of the world.

Biocon Limited Launches Basalog One

Biocon Limited launched Basalog One, a high-end, ready-to-use insulin glargine disposable pen for better blood sugar management for people with diabetes, manufactured in facility.

Biocon Limited Amends its Articles of Association

Biocon Limited amended its articles of association in line with the new companies Act 2003 at its AGM held on July 24, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BIOS:IN 443.50 INR -1.80

BIOS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abeona Therapeutics Inc $4.22 USD +0.07
Cambrex Corp $43.26 USD -0.08
Croda International PLC 2,775 GBp +54.00
Divi's Laboratories Ltd 1,090 INR -46.15
Piramal Enterprises Ltd 910.80 INR -6.95
View Industry Companies

Industry Analysis


Industry Average

Valuation BIOS Industry Range
Price/Earnings 17.0x
Price/Sales 2.8x
Price/Book 2.6x
Price/Cash Flow 11.8x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOCON LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at